8 results on '"Lu, Zhong X"'
Search Results
2. Subclinical hypothyroidism during pregnancy: the Melbourne public hospitals consensus.
- Author
-
Hamblin, Peter S., Sheehan, Penelope M., Allan, Carolyn, Houlihan, Christine A., Lu, Zhong X., Forehan, Simon P., Topliss, Duncan J., Gilfillan, Christopher, Krishnamurthy, Bala, Renouf, Debra, Sztal‐Mazer, Shoshana, and Varadarajan, Suresh
- Subjects
HYPOTHYROIDISM diagnosis ,PREVENTION of psychological stress ,AUTOANTIBODIES ,BLOOD testing ,CONSENSUS (Social sciences) ,EMOTIONS ,ENDOCRINOLOGY ,HYPOTHYROIDISM ,MATERNAL health services ,MEDICAL appointments ,MEDICAL care costs ,MEDICAL protocols ,MEDICAL practice ,DURATION of pregnancy ,PUBLIC hospitals ,REFERENCE values ,THYROTROPIN ,THYROXINE ,PREGNANCY ,THERAPEUTICS - Abstract
Background: Interest in potential adverse outcomes associated with maternal subclinical hypothyroidism (normal free T4, elevated thyroid‐stimulating hormone (TSH)) has increased significantly over recent years. In turn, the frequency of maternal thyroid function testing has risen, despite universal thyroid function screening not being recommended, leading to a marked increase in referrals to obstetric endocrinology clinics. In 2017 the American Thyroid Association revised their diagnostic and management guidelines. Although welcome, these new guidelines contain recommendations that may cause confusion in clinical practice. Aim: To ensure uniform practice in the diagnosis and management of subclinical hypothyroidism in pregnancy across all Melbourne public hospitals. Methods: Endocrinology and obstetric representatives from all Melbourne public hospital networks reviewed the 2017 American Thyroid Association guidelines and other relevant literature to develop a consensus for diagnosing and treating subclinical hypothyroidism during pregnancy in Melbourne. The consensus guidelines were then referred to the Endocrine Society of Australia for comment and endorsement. Results: Consensus was achieved and the guidelines were endorsed by the Council of the Endocrine Society of Australia. Trimester and assay‐specific TSH reference intervals derived from healthy local populations should be used, where available. When unavailable, a TSH cut‐off of 4 mU/L (replacing the previously recommended 2.5 mU/L) should be used to initiate treatment, irrespective of thyroid auto‐antibody status. The recommended starting dose of levothyroxine is 50 μg daily, with a therapeutic TSH target of 0.1–2.5 mU/L. Levothyroxine should generally be ceased after delivery, with some exceptions. Hospitals will ensure smooth transfer of care back to the woman's general practitioner with clear documentation of pregnancy thyroid management and a recommended plan for follow‐up. Conclusion: Fewer women will be classified as having subclinical hypothyroidism during pregnancy, which is likely to lead to reductions in emotional stress, hospital visits, repeated blood tests and financial costs. Uniform clinical practice will occur across Melbourne. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy.
- Author
-
Ekinci, Elif I, Torkamani, Niloufar, Ramchand, Sabashini K, Churilov, Leonid, Sikaris, Ken A, Lu, Zhong X, and Houlihan, Christine A
- Subjects
PROLACTIN ,GESTATIONAL diabetes ,GLUCOSE tolerance tests ,PROLACTIN genes ,CARCINOGENESIS ,PREGNANCY complications - Abstract
It is unknown if high prolactin levels during pregnancy contribute to the development of gestational diabetes. We hypothesized that higher prolactin levels are associated with reduced glucose tolerance, as determined by higher 2-h glucose level from an oral glucose tolerance test in pregnancy. The 75-g oral glucose tolerance test was carried out at 28 weeks of gestation in 69 participants. A multiple regression analysis was used to determine the relationship between serum prolactin and 2-h glucose levels. Multivariable regression analysis showed an independent and significant relationship between third trimester prolactin and 2-h glucose levels post oral glucose tolerance test. Higher prolactin levels were associated with higher glucose levels independent of age, body mass index, gravidity and parity. Higher prolactin levels associated with reduced glucose tolerance in the third trimester of pregnancy suggests the possible independent role of prolactin in the pathogenesis of gestational diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study.
- Author
-
Barr, Elizabeth LM, Reutens, Anne, Magliano, Dianna J, Wolfe, Rory, Lu, Zhong X, Sikaris, Ken A, Tanamas, Stephanie K, Atkins, Robert, Chadban, Steve, Shaw, Jonathan E, and Polkinghorne, Kevan R
- Subjects
CARDIOVASCULAR disease related mortality ,GLOMERULAR filtration rate ,CYSTATINS ,DIABETES ,CREATININE ,DISEASE risk factors - Abstract
Aims Uncertainties about the role of cystatin C-based estimated glomerular filtration rate (eGFR) in the prediction of cardiovascular disease (CVD) beyond traditional CVD risk factors remain. We assessed contributions of eGFR to CVD and mortality in the general population. Methods Using 14 year follow-up data on 9353 adults without a reported history of CVD from the Australian Diabetes, Obesity and Lifestyle study, we assessed the contributions of eGFR (assessed by cystatin C (eGFR
cysC ) and serum creatinine (eGFRcr ) and albuminuria (uACR) to total and CVD mortality. Results After adjusting for age, sex, CVD risk factors and uACR, compared with an eGFRcysC >90 mL/min per 1.73 m2 , eGFRcysC <60 mL/min per 1.73 m2 was associated with 56% and 73% increases in the risks for all-cause and CVD mortality, respectively. The respective changes for the c-statistic when eGFRcysC was added to a risk prediction model were 0.003 (95% confidence interval: 0.001 to 0.005) and 0.002 (95% confidence interval: −0.001 to 0.006). The net proportion of non-events assigned a lower-risk category significantly improved with the addition of eGFR (non-event net reclassification index eGFRcr : 1.0% and eGFRcysC : 1.5%) for all-cause mortality, but for CVD mortality, improvements were only significant when eGFR was combined with uACR. The net proportion of events assigned a higher-risk category was not significantly improved. Conclusion In our community-based cohort, reduced eGFRcysC was associated with all-cause and CVD mortality. The addition of chronic kidney disease measures to risk prediction models improved overall risk stratification among those at low risk as opposed to those at high baseline risk of mortality. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
5. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study.
- Author
-
Daly, Robin M., Gagnon, Claudia, Lu, Zhong X., Magliano, Dianna J., Dunstan, David W., Sikaris, Ken A., Zimmet, Paul Z., Ebeling, Peter R., and Shaw, Jonathan E.
- Subjects
VITAMIN D deficiency ,VITAMIN D in the body ,BIOMARKERS ,AUSTRALIANS ,POPULATION research ,DISEASES - Abstract
Objective Vitamin D deficiency is recognized as a global public health problem, but the population-based prevalence of deficiency and its determinants in Australian adults is not known. This study evaluated the vitamin D status of Australian adults aged ≥25 years and risk factors associated with vitamin D deficiency in this population. Design and Patients We studied a national sample of 11 247 Australian adults enrolled in the 1999/2000 Australian Diabetes, Obesity and Lifestyle (AusDiab) study drawn from 42 randomly selected districts throughout Australia. Measurements Serum concentrations of 25-hydroxyvitamin D [25(OH)D] were measured by immunoassay. Vitamin D deficiency was defined as a concentration <50 nmol/l. Information on demographic and lifestyle factors was derived from interview-administered questionnaires. Results The mean serum 25(OH)D concentration was 63 nmol/l (95% CI: 59-67 nmol/l). Only 4% of the population had a level <25 nmol/l, but the prevalence of vitamin D deficiency (<50 nmol/l) was 31% (22% men; 39% women); 73% had levels <75 nmol/l. The prevalence of vitamin D deficiency increased significantly with age, was greater in women, in those of non-Europid origin, in the obese and those who were physically inactive and with a higher level of education. Deficiency was also more common during winter and in people residing in southern Australia (latitude >35°S); 42% of women and 27% of men were deficient during summer-autumn, which increased to 58% and 35%, respectively, during winter-spring. Conclusion Vitamin D deficiency is common in Australia affecting nearly one-third of adults aged ≥25 years. This indicates that strategies are needed at the population level to improve vitamin D status of Australians. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
6. Frequent walking, but not total physical activity, is associated with increased fracture incidence: A 5-year follow-up of an Australian population-based prospective study (AusDiab).
- Author
-
Nikander, Riku, Gagnon, Claudia, Dunstan, David W., Magliano, Dianna J., Ebeling, Peter R, Lu, Zhong X., Zimmet, Paul Z., Shaw, Jonathan E., and Daly, Robin M.
- Abstract
Current public health physical activity (PA) guidelines recommend that older adults accumulate ≥ 2.5 hours per week of moderate- to vigorous-intensity PA to optimize health. The aim of this study was to examine (1) whether adults who meet the current PA guidelines are at reduced risk of fracture, (2) whether fracture risk varies by PA type/intensity and frequency, and (3) whether prolonged TV viewing, as a marker of sedentary behavior, is associated with fracture risk. This national, population-based prospective study with a 5-year follow-up included 2780 postmenopausal women and 2129 men aged 50 years or older. Incident nontraumatic clinical fractures were self-reported. Overall, 307 (6.3%) participants sustained at least one incident low-trauma fracture (women 9.3%, men 2.3%). Multivariate logistic regression, adjusting for age, body mass index (BMI), physical function, previous fracture history, smoking, and dietary calcium and serum 25-hydroxyvitamin D levels, showed that women who walked more than 3 hours per week or completed at least 6 weekly bouts of walking had a 51% and 56% increased fracture risk, respectively, compared with women who did no walking [odds ratio (OR) time = 1.51, 95% confidence interval (CI) 1.01-2.24; OR frequency = 1.56, 95% CI 1.07-2.27]. However, total and moderate to vigorous PA time and the accumulation of 2.5 hours per week or more of PA and TV viewing time were not associated with incident fractures. In men, there also was an increased fracture risk for those who walked more than 3 hours per week (OR = 2.30, 95% CI 1.06-4.97) compared with those who reported no walking. In conclusion, older adults who adhered to the current PA guidelines were not protected against fragility fractures, but more frequent walking was associated with an increased fracture risk. © 2011 American Society for Bone and Mineral Research. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
7. Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma.
- Author
-
Fedele, Pasquale L., Kay-Weng Choy, Doery, James C. G., Grigoriadis, George, Shortt, Jake, and Lu, Zhong X.
- Subjects
MULTIPLE myeloma treatment ,TEST validity ,BETA 2-microglobulin - Abstract
A letter to the editor is presented which discusses the validity of the international staging system (ISS) used in multiple myeloma treatment using the two parameters such as serum albumin and beta-2 microglobulin (β2M).
- Published
- 2014
- Full Text
- View/download PDF
8. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients.
- Author
-
Trambas, Christina M., Sikaris, Kenneth A., Zhong X. Lu, and Lu, Zhong X
- Abstract
A letter to the editor is presented in response to the article "Interference by biotin therapy on measurement of thyroid-stimulating hormone (TSH) and free thyroxine 4 (FT4) by enzyme immunoassay on Boehringer Mannheim ES700 analyser," by J. G. Henry, S. Sobki and N. Arafat in a previous journal issue.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.